Bloqueios químicos como auxiliares na reabilitação de crianças com paralisia cerebral

a importância de uma visão multidisciplinar

Autores

  • Clarisse Potasz Terapeuta ocupacional, Doutoranda do Setor de Neuro-Sono, Departamento de Medicina da Universidade Federal de São Paulo, São Paulo-SP, Brasil.

DOI:

https://doi.org/10.34024/rnc.2010.v18.8481

Palavras-chave:

revisão aberta

Resumo

.

Métricas

Carregando Métricas ...

Downloads

Não há dados estatísticos.

Referências

Bernardi BM, Motta AAP, Allegretti KMG, Monteiro VC, Borges HC, Chamlian TR, et al. Efeitos do Treino Funcional pós Bloqueio Químico em Crianças com Paralisia Cerebral: Relato de Caso. Rev Neurocienc 2010;18: 166-71.

Stanley F, Blair E, Alberman E. Cerebral palsies: Epidemiology and Causal Pathways. Clinics in Developmental Medicine No . 151. London: Mac Keith Press, 2000, 248p.

Maria BL. Cerebral Palsy and Spasticity: Time to Empower Child Neurology with a Comprehensive Review. J Child Neurol 2001;16:1.

Gesell A. A Criança do 0 aos 5 Anos. São Paulo: Martins Fontes, 1987, 392p.

Blitzer A, Binder WJ, Aviv JE, Keen MS, Brin MF. The management of hyperfunctional facial lines with botulinum toxin: a collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997;123:389-92.

Park ES, Park CI, Chang HC, Park CW, Lee DS. The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-tostand transfer in children with spastic diplegic cerebral palsy. Clin Rehabil 2006; 20:668-74.

Rosales RL, Bigalke H, Dressler D. Pharmacology of botulinum toxin: differences between type A preparations. Eur J Neurol 2006;13(suppl 1):2-10.

Poewe W, Schelosky L, Kleedorfer B, Heinen F, Wagner M, Deuschl G. Treatment of spasmodic torticollis with local injections of botulinum toxin. One year follow up in 37 patients. J Neurol 1992;239:21-5.

Brin MF, Blitzer A. Botulinum toxin: dangerous terminology errors [letter]. J R Soc Med 1993;86:493-9.

Park ES, Park CI, Chang HC, Park CW, Lee DS. The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-tostand transfer in children with spastic diplegic cerebral palsy. Clin Rehabil 2006; 20:668-74.

Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 1994;9:213-7.

Hu GC, Chuang YC, Liu JP, Chien KL, Chen YM, Chen YF. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes. Clin Rehabil 2009;23:64-71.

On AY, Kirazli Y, Kismali B. Mechanisms of action of phenol block and botulinus toxin type A in relieving spasticity: Electrophysiologic investigation and follow-up. Am J Phys Med Rehabil 1999;78:344-9.

Gracies JM, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity Part I: Local treatments. Muscle Nerve 1997;6(Suppl):S61-9.

Glenn MB. Nerve blocks. In: Glenn MB, Whyte J (eds). The Practical Management of Spasticity in Children and Adults. Philadelphia: Lea & Febiger, 1990, p.227-58.

Goldstein EM. Spasticity Management: An Overview. J Child Neurol 2001;16:16-23.

Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7.

Flett PJ, Stern LM, Waddy H, Connell TM, Seeger JD, Gibson SK. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health 1999;35:71-7.

Reddihough DS, King JA, Coleman GJ, Fosang A, McCoy AT, Thomason P, et al. Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy. Dev Med Child Neurol 2002;44:820-7.

Sätilä H, Iisalo T, Pietikäinen T, Seppänen RL, Salo M, Koivikko M, et al. Botulinum toxin treatment of spastic equines in cerebral palsy: a randomized trial comparing two injection sites. Am J Phys Med Rehabil 2005;84:355-65.

Wissel J, Heinen F, Schenkel A, Doll B, Ebersbach G, Muller J, et al. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of “high-dose” versus “low-dose” treatment. Neuropediatrics 1999;30:120-4.

Tardieu G, Shentoub S, Delarue R. Research on a technique for measurement of spasticity. Rev Neurol (Paris) 1954;91:143-4.

Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 1999;6(Suppl 4):S23-35.

Fosang AL, Galea MP, McCoy AT, Reddihough DS, Story I. Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Dev Med Child Neurol 2003;45:664-70.

Criswell SR, Crowner BE, Racette BA. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy. Neurosurg Focus 2006;21:1-7.

Pandyan AD, Johnson GR, Price CIM, Curless RH, Barnes MP, Rodgers H. A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity. Clin Rehabil 1999;13:373-83.

Wartenburg R. Pendulousness of the legs as a diagnostic test. Neurology 1951;1:18-24.

Ward AB. Spasticity treatment with botulinum toxins. J Neural Transm 2008;115:607-16.

Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res 1981;4:483-92.

Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford University Press, 1992, p.408.

Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, et al. For the Botox Post-Stroke Spasticity Study Group Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347:395-400.

Butler C, Darrah J. Effects of neurodevelopmental treatment (NDT) for cerebral palsy: An AACPDM evidence report. Dev Med Child Neurol 2001;43:778-90.

Gorter JW, Verschuren O, Riel L, Ketelaar M. The relationship between spasticity in young children (18 months of age) with cerebral palsy and their gross motor function. BMC Musculoskel Dis 2009;10:108-18.

Palisano RJ. Research on the effectiveness of neurodevelopmental treatment. Ped Phys Ther 1992;3:143-8.

Rosenbaum PL, Russell DJ, Cadman DT, Gowland C, Jarvis S, Hardy S. Issues in measuring change in motor function in children with cerebral palsy: a special communication. Phys Ther 1990; 70:125-31.

Ingram TTS. Paediatric Aspects of Cerebral Palsy. London: Livingstone, 1964, p. 515.

Reimers J. A scoring system for evaluation of ambulation in cerebral palsied patients. Dev Med Child Neurol 1972;14:332-5.

Palisano RJ, Rosenbaum PL, Walter S, Russel D, Wood E, Gallupi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-23.

Russell DJ, Rosenbaum PL, Gowland C. Gross Motor Function Measure: A Measure of Gross Motor Function in Cerebral Palsy. 2nd ed. Ontario: McMaster University, 1993, 244p.

Palisano RJ, Hanna SE, Rosenbaum PL, Russell DJ, Walter SD, Wood EP, et al. Validation of a Model of Gross Motor Function for Children With Cerebral Palsy. Phys Ther 2000;80:974-85.

Beckung E, Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol 2002;44:309-16.

OPAS (Organização Panamericana de Saúde). CIF: Classificação Internacional de Funcionalidade, Incapacidade e Saúde. São Paulo: EDUSP, 2003, 328p.

Farias N, Buchalla CM. A Classificação Internacional de Funcionalidade, Incapacidade e Saúde da Organização Mundial de Saúde: conceitos, usos e perspectivas. Rev Bras Epidemiol 2005;8:187-93.

Guerzoni VPD, Barbosa AP, Borges ACC, Chagas PSC, Gontijo APB, Eterovick F, et al. Análise das intervenções de terapia ocupacional no desempenho das atividades de vida diária em crianças com paralisia cerebral: uma revisão sistemática da literatura. Rev Bras Saúde Mater Infant 2008;8:17-25.

Lammi BM, Law M. The effects of family-centered functional therapy on the occupational performance of children with cerebral palsy. Can J Occup Ther 2003;70:285-97.

Schenker W, Coster W, Parush S. Participation and activity performance of students with cerebral palsy within the school environment. Disabil Rehabil 2005;27:539-52.

Hammal D, Stephen NJ, Colver AF. Participation of children with cerebral palsy is influenced by where they live. Dev Med Child Neurol 2004;46:292-8.

Palisano RJ, Tieman BL, Walter SD, Bartlett DJ, Rosenbaum PL, Russell D, et al. Effect of environmental setting on mobility methods of children with cerebral palsy. Dev Med Child Neurol 2003;45:113-20.

Barros R. Neurociências e psicologia analítica: a memória (Endereço na Internet). Anais do 2ª Jornada de Psicologia Jungiana de Bauru e Região (atualizado em: 2003; acessado em: 06/2010). Disponível em <http://www.ipjbr.com/2003_2_jornada_7_mostra.pdf#page=253>.

Monserrat J. Engramas neuronales y teoría de la mente. Pensamiento: Rev Investig Inform Filos 2001;57:177-211.

Tieman BL, Palisano RJ, Gracely EJ, Rosenbaum PL. Gross motor capability and performance of mobility in children with cerebral palsy: a comparison across home, school, and outdoors/community settings. Phys Ther 2004;84:419-29.

Üstün TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The International Classification of Functioning, Disability and Health: a new tool for understanding disability and health. Disabil Rehabil 2003;25:565-71.

Boyd RN, Hays RM. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Eur J Neurol 2001;8:1-20.

Silva MS, Beltrami-Daltrário SMB. Paralisia cerebral: desempenho funcional após treinamento da marcha em esteira. Fisioter Mov 2008;21:109-15.

Mancini MC, Fiúza PM, Rebelo JM, Magalhães LC, Coelho ZAC, Paixão ML, et al. Comparação do desempenho de atividades funcionais em crianças com desenvolvimento normal e crianças com paralisia cerebral. Arq Neuropsiquiatr 2002;60:446-52.

Russman BS, Tilton A, Gormley Jr ME. Cerebral Palsy: A Rational Approach to a Treatment Protocol, and the Role of Botulinum Toxin in Treatment. Muscle Nerve Suppl 1997;6:S181-93.

Boyd R, Hays R. Outcome measurement in children with cerebral palsy: an ICIDH-2 approach. Eur J Neurol 2001;817(Suppl. 5):167-77.

Pidcock FS. The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy. J Pediatr 2004;145:S33-5.

Downloads

Publicado

2010-06-30

Como Citar

Potasz, C. (2010). Bloqueios químicos como auxiliares na reabilitação de crianças com paralisia cerebral: a importância de uma visão multidisciplinar. Revista Neurociências, 18(2), 172–178. https://doi.org/10.34024/rnc.2010.v18.8481

Edição

Seção

Relato de Caso
##plugins.generic.dates.received## 2019-02-17
##plugins.generic.dates.published## 2010-06-30

Artigos Semelhantes

1 2 3 4 5 6 7 8 9 10 > >> 

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.